TCF/LEFs and Wnt signaling in the nucleus

Cold Spring Harbor Perspectives in Biology

Volumn 4, Issue 11, 2012, Pages

  Cadigan, Ken M ^a   Waterman, Marian L ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; HISTONE; T CELL FACTOR PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENE STRUCTURE; GENETICS; METABOLISM; MOLECULAR EVOLUTION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SPECIES DIFFERENCE; WNT SIGNALING PATHWAY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BETA CATENIN; CELL NUCLEUS; EVOLUTION, MOLECULAR; GENE COMPONENTS; GENE EXPRESSION REGULATION; HISTONES; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SPECIES SPECIFICITY; TCF TRANSCRIPTION FACTORS; WNT SIGNALING PATHWAY;

INVERTEBRATA; METAZOA; VERTEBRATA;

EID: 84868540323     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a007906     Document Type: Article

References (194)

1. Adamska M, Larroux C, Adamski M, Green K, Lovas E, Koop D, Richards GS, Zwafink C, Degnan BM. 2010. Structure and expression of conserved Wnt pathway components in the desmosponge Amphimedon queenslandica. Evol Dev 12: 494-518.
2. Almeida M, Han L, Martin-Millan M, O'Brien CA, Manolaga SC. 2007. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting β-catenin from T cell factor-to forkhead box O-mediated transcription. J Biol Chem 282: 27298-27305.
3. Angus-Hill ML, Elbert KM, Hidalgo J, Capecchi MR. 2011. T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis. Proc Natl Acad Sci 108: 4914-4919.
4. Arce L, Yokoyama NN, Waterman ML. 2006. Diversity of LEF/TCF action in development and disease. Oncogene 25: 7492-7504.
5. Arce L, Pate KT, Waterman ML. 2009. Groucho binds two conserved regions of LEF-1 forHDAC-dependent repression. BMC Cancer 9: 159.
6. Archbold HC, Yang YX, Chen L, Cadigan KM. 2012. How do they do Wnt they do?: Regulation of transcription by the Wnt/β-catenin pathway. Acta Physiol (Oxford) 204: 74-109.
7. Atcha FA, Syed A, Wu B, HoverterNP, YokoyamaNN, Ting JH, Munguia JE, Mangalam HJ, Marsh JL, Waterman ML. 2007. A unique DNA binding domain converts T-cell factors into strong Wnt effectors. MolCell Biol 27: 8352-8363.
8. Badis G, Berger MF, Philippakis AA, Talukder S, Gehrke AR, Jaeger SA, Chan ET, Metzler G, Vedenko A, Chen X, et al. 2009. Diversity and complexity in DNA recognition by transcription factors. Science 324: 1720-1723.
9. Baker CM, Verstuyf A, Jensen KB, Watt FM. 2010. Differential sensitivity of epidermal cell subpopulations to β-catenin-induced ectopic hair follicle formation. Dev Biol 343: 40-50.
10. Bass AJ, Lawrence MS, Brace LE, Ramos AH, Drier Y, Cibulskis K, Sougnez C, Voet D, Saksena G, Sivachenko A, et al. 2011. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat Genet 43: 964-968.
11. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grossched R, Birchmeier W. 1996. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382: 638-642.
12. Beildeck ME, Gelmann EP, ByersSW. 2010. Cross-regulation of signaling pathways: An example of nuclear hormone receptors and the canonical Wnt pathway. Exp Cell Res 316: 1763-1772.
13. Berger SL. 2007. The complex language of chromatin regulation during transcription. Nature 447: 407-412.
14. Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, Cerqueira GC, Mashiyama ST, Al-Lazikani B, Andrad LF, Ashton PD, et al. 2009. The genome of the blood fluke Schistosoma mansoni. Nature 460: 352-358.
15. Bhambhani C, Chang JL, Akey DL, Cadigan KM. 2011. The oligomeric state of CtBP determines its role as a transcriptional co-activator and co-repressor ofWingless targets. EMBO J 30: 2031-2043.
16. Bierie B, Nozawa M, Renou JP, Shillingford JM, Morgan F, Oka T, Taketo MM, Cardiff RD, Miyoshi K, Wagner KU, et al. 2003. Activation of β-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation. Oncogene 22: 3875-3887.
17. Billin AN, Thirlwell H, Ayer DE. 2000. β-Catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator. Mol Cel Biol 20: 6882-6890.
18. Blahnik KR, Dou L, O'Geen H, McPhillips T, Xu X, Cao AR, Iyengar S, Nicolet CM, Ludäscher B, Korf I, et al. 2010. Sole-Search: An integrated analysis program for peak detection and functional annotation using ChIP-seq data. Nucleic Acids Res 38: e13.
19. Blythe SA, Cha SW, Tadjuidje E, Heasman J, Klein PS. 2010. β-Catenin primes organizer gene expression by recruiting a histone H3 arginine 8 methyltransferase, Prmt2. Dev Cell 19: 220-231.
20. Bottomly D, Kyler SL, McWeeney SK, Yochum GS. 2010. Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res 38: 5735-5745.
21. Brannon M, Brown JD, Bates R, Kimelman D, Moon RT. 1999. XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development. Development (Cambridge, England) 126: 3159-3170.
22. Brantjes H, Roose J, van De Wetering M, Clevers H. 2001. All Tcf HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Res 29: 1410-1419.
23. Brunner E, Peter O, Schweizer L, Basler K. 1997. Pangolin encodes a Lef-1 homologue that acts downstream of Armadillo to transduce theWingless signal in Drosophila. Nature 385: 829-833.
24. Cadigan KM. 2012. TCFs and Wnt/β-catenin signaling more than one way to throw the switch. Curr Top Dev Biol 98: 1-34.
25. Cadigan KM, Peifer M. 2009. Wnt signaling from development to disease: Insights from model systems. Col Spring Harb Perspect Biol 1: 002881.
26. Calvo D, Victor M, Gay F, Sui G, Luke MP, Dufourcq P, We G, Maduro M, Rothman J, Shi Y. 2001. A POP-1 repressor complex restricts inappropriate cell type-specific gene transcription during Caenorhabditis elegans embryogenesis. EMBO J 20: 7197-7208.
27. Carrera I, Janody F, Leeds N, Duveau F, Treisman JE. 2008. Pygopus activates Wingless target gene transcription through the mediator complex subunits Med12 an Med13. Proc Natl Acad Sci 105: 6644-6649.
28. Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, Nejjari C, Patsch W, Chikri M, Meyre D, et al. 2007. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: A global meta-analysis. J Mol Med (Berl) 85: 777-782.
29. Cavallo RA, Cox RT, Moline MM, Roose J, Polevoy GA, Clevers H, Peifer M, Bejsovec A. 1998. Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature 395: 604-608.
30. ChangMV, Chang JL, Gangopadhyay A, Shearer A, Cadiga KM. 2008. Activation of wingless targets requires bipartite recognition ofDNAby TCF. Curr Biol 18: 1877-1881.
31. Chen G, Fernandez J, Mische S, Courey AJ. 1999. A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. Genes Dev 13: 2218-2230.
32. Chen SY, Wulf G, Zhou XZ, Rubin MA, Lu KP, Balk SP. 2006. Activation of β-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-β-catenin interaction. Mol Cell Biol 26: 929-939.
33. Chen J, Luo Q, Yuan Y, Huang X, CaiW, Li C, Wei T, Zhan L, Yang M, Liu Q, et al. 2010. Pygo2 associates with MLL2 histone methyltransferase and GCN5 histone acetyltransferase complexes to augment Wnt target gene expression and breast cancer stem-like cell expansion. Mol Cell Biol 30: 5621-5635.
34. Chesire DR, Isaacs WB. 2002. Ligand-dependent inhibition of β-catenin/TCF signaling by androgen receptor. Oncogene 21: 8453-8469.
35. Chesire DR, Ewing CM, Sauvageot J, Bova GS, Isaacs WB. 2000. Detection and analysis of β-catenin mutations in prostate cancer. The Prostate 45: 323-334.
36. Cole MF, Johnstone SE, Newman JJ, Kagey MH, Young RA. 2008. Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev 22: 746-755.
37. Cronauer MV, Schulz WA, Ackermann R, Burchardt M. 2005. Effects of WNT/β-catenin pathway activation on signaling through T-cell factor and androgen receptor in prostate cancer cell lines. Int J Oncol 26: 1033-1040.
38. Culig Z, Klocker H, Bartsch G, Hobisch A. 2002. Androgen receptors in prostate cancer. Endocr Relat Cancer 9: 155-170.
39. Daniels DL, Weis WI. 2005. β-Catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol 12: 364-371.
40. Doria A, Patti ME, Kahn CR. 2008. The emerging genetic architecture of type 2 diabetes. Cell Metab 8: 186-200.
41. Duval A, Rolland S, Tubacher E, Bui H, Thomas G, Hameli R. 2000. The human T-cell transcription factor-4 gene: Structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res 60: 3872-3879.
42. Essers MA, de Vries-Smits LM, Barker N, Polderman PE, Burgering BM, Korswagen HC. 2005. Functional interaction between β-catenin and FOXO in oxidative stress signaling. Science 308: 1181-1184.
43. Fang M, Li J, Blauwkamp T, Bhambhani C, Campbell N, Cadigan KM. 2006. C-Terminal-binding protein directly activates and represses Wnt transcriptional targets i Drosophila. EMBO J 25: 2735-2745.
44. Fiedler M, Sanchez-Barrena MJ, Nekrasov M, Mieszczane J, Rybin V, Muller J, Evans P, Bienz M. 2008. Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex. Mol Cell 30: 507-518.
45. -/-mice. Genes Dev 13: 709-717.
46. Ghogomu SM, van Venrooy S, Ritthaler M, Wedlich D, Gradl D. 2006. HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription. J Bio Chem 281: 1755-1764.
47. Giese K, Amsterdam A, Grosschedl R. 1991. DNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1. Genes Dev 5: 2567-2578.
48. Giese K, Kingsley C, Kirshner JR, Grosschedl R. 1995. Assembly and function of a TCR a enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev 9: 995-1008.
49. Goentoro L, Kirschner MW. 2009. Evidence that foldchange, and not absolute level, of β-catenin dictates Wnt signaling. Mol Cell 36: 872-884.
50. Gradl D, Konig A, Wedlich D. 2002. Functional diversity of Xenopus lymphoid enhancer factor/T-cell factor transcription factors relies on combinations of activating and repressing elements. J Biol Chem 277: 14159-14171.
51. Graham TA, Weaver C, Mao F, Kimelman D, Xu W. 2000. Crystal structure of a β-catenin/Tcf complex. Cell 103: 885-896.
52. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsso V, Helgadottir A, et al. 2006. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38: 320-323.
53. 2/2embryos. EMBO J 23: 1825-1833.
54. Gu B, Sun P, Yuan Y, Moraes RC, Li A, Teng A, Agrawal A, Rheaume C, Bilanchone V, Veltmaat JM, et al. 2009. Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation. J Cell Biol 185: 811-826.
55. Haegebarth A, Clevers H. 2009. Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol 174: 715-721.
56. Hallikas O, Taipale J. 2006. High-throughput assay for determining specificity and affinity of protein-DNA binding interactions. Nat Protoc 1: 215-222.
57. Hamada F, Bienz M. 2004. The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF. Dev Cell 7: 677-685.
58. Hatzis P, van der Flier LG, van Driel MA, GuryevV, Nielsen F, Denissov S, Nijman IJ, Koster J, Santo EE, Welboren W, et al. 2008. Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol Cell Biol 28: 2732-2744.
59. Herman M. 2001. C. elegans POP-1/TCF functions in a canonical Wnt pathway that controls cell migration and in a noncanonical Wnt pathway that controls cell polarity. Development (Cambridge, England) 128: 581-590.
60. Hikasa H, Sokol SY. 2011. Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2. J Bio Chem 286: 12093-12100.
61. Hikasa H, Ezan J, Itoh K, Li X, KlymkowskyMW, Sokol SY. 2010. Regulation of TCF3 by Wnt-dependent phosphorylation during vertebrate axis specification. Dev Cell 19: 521-532.
62. Houston DW, Kofron M, Resnik E, Langland R, Destree O, Wylie C, Heasman J. 2002. Repression of organizer genes in dorsal and ventral Xenopus cells mediated by materna XTcf3. Development (Cambridge, England) 129: 4015-4025.
63. Hovanes K, Li TWH, Waterman ML. 2000. The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res 28: 1994-2003.
64. Hovanes K, Li TW, Munguia JE, Truong T, Milovanovic T, Lawrence Marsh J, Holcombe RF, Waterman ML. 2001. β-Catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 28: 53-57.
65. Hsu S-C, Galceran J, Grosschedl R. 1998. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with β-catenin. Mo Cell Biol 18: 4807-4818.
66. Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann B, Kemler R. 1996. Nuclear localization of β-catenin by interaction with transcription factor LEF-1. Mech Dev 59: 3-10.
67. Ishitani T, Ninomiya-Tsuji J, Nagai S, Nishita M, Meneghini M, Barker N, Waterman M, Bowerman B, Clevers H, Shibuya H, et al. 1999. The TAK1-NLK-MAPK-related pathway antagonizes signalling between β-catenin and transcription factor TCF. Nature 399: 798-802.
68. 2+pathway to antagonize Wnt/β-catenin signaling. Mol Cell Biol 23: 131-139.
69. Jessen S, Gu B, Dai X. 2008. Pygopus and the Wnt signaling pathway: A diverse set of connections. Bioessays 30: 448-456.
70. Jimenez J, Jang GM, Semler BL, Waterman ML. 2005. An internal ribosome entry site mediates translation of lymphoid enhancer factor-1. RNA 11: 1385-1399.
71. Kaidi A, Williams AC, Paraskeva C. 2007. Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 9: 210-217.
72. Kennell JA, O'Leary EE, Gummow BM, Hammer GD, Mac-Dougald OA. 2003. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with β-catenin to coactivate C/EBPa and steroidogenic factor 1 transcription factors. Mol Cell Biol 23: 5366-5375.
73. Kessler R, Hausmann G, Basler K. 2009. ThePHDdomain is required to link Drosophila Pygopus to Legless/β-catenin and not to histone H3. Mech Dev 126: 752-759.
74. Kidd AR III, Miskowski JA, Siegfried KR, Sawa H, Kimble J. 2005. A β-catenin identified by functional rather than sequence criteria and its role in Wnt/MAPK signaling. Cell 121: 761-772.
75. Kim CH, Oda T, Itoh M, Jiang D, Artinger KB, Chandrasekharapp SC, Driever W, Chitnis AB. 2000. Repressor activity of Headless/Tcf3 is essential for vertebrate head formation. Nature 407: 913-916.
76. Kim CH, Neiswender H, Baik EJ, XiongWC, Mei L. 2008. β-Catenin interacts with MyoD and regulates its transcription activity. Mol Cell Biol 28: 2941-2951.
77. King N, Westbrook MJ, Young SL, Kuo A, Abedin M, Chapman J, Fairclough S, Hellsten U, Isogai Y, Letunic I, et al. 2008. The genome of the choanoflagellateMonosiga brevicollis and the origin of metazoans. Nature 451: 783-788.
78. Kioussi C, Briata P, Baek SH, Rose DW, Hamblet NS, Herman T, Ohgi KA, Lin C, Gleiberman A, Wang J, et al. 2002. Identification of a Wnt/Dvl/β-catenin →Pitx2 pathway mediating cell-type-specific proliferation during development. Cell 111: 673-685.
79. Knirr S, Frasch M. 2001. Molecular integration of inductive and mesoderm-intrinsic inputs governs even-skipped enhancer activity in a subset of pericardial and dorsal muscle progenitors. Dev Biol 238: 13-26.
80. -/-colon carcinoma. Science 275: 1784-1787.
81. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, Clevers H. 1998a. Depletion of epithelial stemcell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19: 379-383.
82. Korinek V, Barker N, Willert K, Molenaar M, Roose J, Wagenaa G, Markman M, LamersW, Destree O, Clevers H. 1998b. Two members of the Tcf family implicated in Wnt/β-catenin signaling during embryogenesis in the mouse. Mol Cell Biol 18: 1248-1256.
83. Kormish JD, Sinner D, Zorn AM. 2010. Interactions between SOX factors and Wnt/β-catenin signaling in development and disease. Dev Dyn 239: 56-68.
84. Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterje S, Murone M, Zullig S, Basler K. 2002. Wnt/ wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear β-catenin-TCF complex. Cell 109: 47-60.
85. 2/2mice. Genes Dev 16: 3173-3185.
86. Lam N, Chesney MA, Kimble J. 2006. Wnt signaling and CEH-22/tinman/Nkx2.5 specify a stem cell niche in C. elegans. Curr Biol 16: 287-295.
87. Laudes M. 2011. Role of WNTsignalling in the determination of human mesenchymal stem cells into preadipocytes. J Mol Endocrinol 46: R65-R72.
88. Le Bacquer O, Shu L, Marchand M, Neve B, Paroni F, Kerr Conte J, Pattou F, Froguel P, Maedler K. 2011. TCF7L2 splice variants have distinct effects on β-cell turnover and function. Hum Mol Genet 20: 1906-1915.
89. Li TW, Ting JH, Yokoyama NN, Bernstein A, van de Weterin M, Waterman ML. 2006. Wnt activation and alternative promoter repression of LEF1 in colon cancer. Mo Cell Biol 26: 5284-5299.
90. Li Z, Nie F, Wang S, Li L. 2011. Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation. Proc Natl Acad Sci 108: 3116-3123.
91. Lin R, Hill RJ, Priess JR. 1998. POP-1 and anterior-posterior fate decisions in C. elegans embryos. Cell 92: 229-239.
92. Linggi BE, Brandt SJ, SunZW, HiebertSW. 2005. Translating the histone code into leukemia. J Cell Biochem 96: 938-950.
93. Liu F, van den BroekO, DestreeO, Hoppler S. 2005. Distinct roles for Xenopus Tcf/Lef genes in mediating specific responses to Wnt/β-catenin signalling in mesoderm development. Development (Cambridge, England) 132: 5375-5385.
94. Liu J, Phillips BT, Amaya MF, Kimble J, Xu W. 2008a. The C. elegans SYS-1 protein is a bona fide β-catenin. Dev Cell 14: 751-761.
95. Liu YI, Chang MV, Li HE, Barolo S, Chang JL, Blauwkam TA, Cadigan KM. 2008b. The chromatin remodelers ISWI and ACF1 directly repressWingless transcriptional targets. Dev Biol 323: 41-52.
96. Lluis F, Ombrato L, Pedone E, Pepe S, Merrill BJ, Cosma MP. 2011. T-cell factor 3 (Tcf3) deletion increases somatic cell reprogramming by inducing epigenome modifications. Proc Natl Acad Sci 108: 11912-11917.
97. Lo MC, Gay F, Odom R, Shi Y, Lin R. 2004. Phosphorylation by the β-catenin/MAPK complex promotes 14-3-3-mediated nuclear export of TCF/POP-1 in signal-responsive cells in C. elegans. Cell 117: 95-106.
98. Locke JM, Da Silva Xavier G, Rutter GA, Harries LW. 2011. An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes. Diabetologia 54: 3078-3082.
99. Logan CY, Nusse R. 2004. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810.
100. Love JJ, Li X, Case DA, Giese K, Grosschedl R, Wright PE. 1995. Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature 376: 791-795.
101. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, Sjogren M, Ling C, Eriksson KF, Lethagen AL, et al. 2007. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117: 2155-2163.
102. Lyu J, Jho EH, Lu W. 2011. Smek promotes histone deacetylation to suppress transcription of Wnt target gene brachyury in pluripotent embryonic stem cells. Cell Res 21: 911-921.
103. Maduro MF, Lin R, Rothman JH. 2002. Dynamics of a developmental switch: Recursive intracellular and intranuclear redistribution of Caenorhabditis elegans POP-1 parallels Wnt-inhibited transcriptional repression. Dev Biol 248: 128-142.
104. Mahmoudi T, Li VS, Ng SS, Taouatas N, Vries RG, Mohamme S, Heck AJ, Clevers H. 2009. The kinase TNIK is an essential activator of Wnt target genes. EMBO J 28: 3329-3340.
105. Mahmoudi T, Boj SF, Hatzis P, Li VS, Taouatas N, Vries RG, Teunissen H, Begthel H, Korving J, Mohammed S, et al. 2010. The leukemia-associated Mllt10/Af10-Dot1l are Tcf4/β-catenin coactivators essential for intestinal homeostasis. PLoS Biol 8: e1000539.
106. Malloy PJ, Feldman D. 2011. The role of vitamin D receptor mutations in the development of alopecia. Mol Cell Endocrinol 347: 90-96.
107. Malloy PJ, Xu R, Peng L, Clark PA, FeldmanD. 2002. A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Mo Endocrinol (Baltimore, MD) 16: 2538-2546.
108. Masiello D, Chen SY, Xu Y, Verhoeven MC, Choi E, Hollenber AN, Balk SP. 2004. Recruitment of β-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells. Mo Endocrinol (Baltimore, MD) 18: 2388-2401.
109. Mazumdar J, O'Brien WT, Johnson RS, LaManna JC, Chave JC, Klein PS, Simon MC. 2010. O2 regulates stem cells through Wnt/β-catenin signalling. Nat Cell Biol 12: 1007-1013.
110. Merrill BJ, Pasolli HA, Polak L, Rendl M, Garcia-Garcia MJ, Anderson KV, Fuchs E. 2004. Tcf3: A transcriptional regulator of axis induction in the early embryo. Development (Cambridge, England) 131: 263-274.
111. Mohan M, Herz HM, Takahashi YH, Lin C, Lai KC, Zhang Y, Washburn MP, Florens L, Shilatifard A. 2010. Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom). Genes Dev 24: 574-589.
112. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, Roose J, Destree O, Clevers H. 1996. XTCF-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 86: 391-399.
113. Moore AC, Amann JM, Williams CS, Tahinci E, Farmer TE, Martinez JA, Yang G, Luce KS, Lee E, Hiebert SW. 2008. Myeloid translocation gene family members associate with T-cell factors (TCFs) and influence TCF-dependent transcription. Mol Cell Biol 28: 977-987.
114. Mosimann C, Hausmann G, Basler K. 2009. β-Catenin hits chromatin: Regulation of Wnt target gene activation. Nat Rev 10: 276-286.
115. Mulholland DJ, Cheng H, Reid K, Rennie PS, Nelson CC. 2002. The androgen receptor can promote β-catenin nuclear translocation independently of adenomatous polyposis coli. J Biol Chem 277: 17933-17943.
116. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC. 2005. Interaction of nuclear receptors with the Wnt/β-catenin/ Tcf signaling axis: Wnt you like to know? Endocr Rev 26: 898-915.
117. Mullighan CG, Zhang J, Kasper LH, Lerach S, Payne-Turner D, Phillips LA, Heatley SL, Holmfeldt L, Collins-Underwood JR, Ma J, et al. 2011. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471: 235-239.
118. Najdi R, Syed A, Arce L, Theisen H, Ting JH, Atcha F, Nguyen AV, Martinez M, Holcombe RF, Edwards RA, et al. 2009. AWnt kinase network alters nuclear localization of TCF-1 in colon cancer. Oncogene 28: 4133-4146.
119. Newton IP, Kenneth NS, Appleton PL, Nathke I, Rocha S. 2010. Adenomatous polyposis coli and hypoxia-inducible factor-1a have an antagonistic connection. Mol Cel Biol 21: 3630-3638.
120. Nguyen H, Merrill BJ, Polak L, Nikolova M, Rendl M, Shave TM, Pasolli HA, Fuchs E. 2009. Tcf3 and Tcf4 are essential for long-term homeostasis of skin epithelia. Nat Genet 41: 1068-1075.
121. Niu Y, Chang TM, Yeh S, Ma WL, Wang YZ, Chang C. 2010. Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails. Oncogene 29: 3593-3604.
122. Norton L, Fourcaudot M, Abdul-Ghani MA, Winnier D, Mehta FF, Jenkinson CP, Defronzo RA. 2011. Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism. Diabetologia 54: 3132-3142.
123. Olson LE, Tollkuhn J, Scafoglio C, Krones A, Zhang J, Ohgi KA, Wu W, Taketo MM, Kemler R, Grosschedl R, et al. 2006. Homeodomain-mediated β-catenin-dependent switching events dictate cell-lineage determination. Cell 125: 593-605.
124. Oosterwegel M, van de Wetering M, Timmerman J, Kruisbeek A, Destree O, Meijlink F, Clevers H. 1993. Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis. Development (Cambridge, England) 118: 439-448.
125. Orsulic S, Peifer M. 1996. An in vivo structure-function study of armadillo, the β-catenin homologue, reveals both separate and overlapping regions of the protein required for cell adhesion and for wingless signaling. J Cel Biol 134: 1283-1300.
126. Ou CY, LaBonte MJ, Manegold PC, So AY, Ianculescu I, Gerke DS, Yamamoto KR, Ladner RD, Kahn M, Ki JH, et al. 2011. A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expression. Mol Cancer Res 9: 660-670.
127. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M, et al. 2001. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J Cell Biol 154: 369-387.
128. Palmer HG, Anjos-Afonso F, Carmeliet G, Takeda H, Wat FM. 2008. The vitamin D receptor is a Wnt effector that controls hair follicle differentiation and specifies tumor type in adult epidermis. PLoS ONE 3: e1483.
129. Parker DS, Blauwkamp T, Cadigan KM. 2007. Wnt/β-catenin-mediated transcriptional regulation. Adv Devel Biol 17: 1-61.
130. Parker DS, Ni YY, Chang JL, Li J, Cadigan KM. 2008. Wingless signaling induces widespread chromatin remodeling of target loci. Mol Cell Biol 28: 1815-1828.
131. Pawlowski JE, Ertel JR, Allen MP, Xu M, Butler C, Wilso EM, Wierman ME. 2002. Liganded androgen receptor interaction with β-catenin: Nuclear co-localization and modulation of transcriptional activity in neuronal cells. J Biol Chem 277: 20702-20710.
132. Phillips BT, Kimble J. 2009. A newlook at TCFand β-catenin through the lens of a divergent C. elegans Wnt pathway. Dev Cell 17: 27-34.
133. Polakis P. 2007. The many ways of Wnt in cancer. Curr Opin Genet Dev 17: 45-51.
134. Poy F, Lepourcelet M, Shivdasani RA, Eck MJ. 2001. Structure of a human Tcf4-β-catenin complex. Nat Struct Biol 8: 1053-1057.
135. Prieve MG, Guttridge KL, Munguia JE, Waterman ML. 1998. Differential importin-a recognition and nuclear transport by nuclear localization signals within the highmobility-group DNA binding domains of lymphoid enhancer factor 1 and T-cell factor 1. Mol Cell Biol 18: 4819-4832.
136. Prokunina-Olsson L, Kaplan LM, Schadt EE, Collins FS. 2009a. Alternative splicing of TCF7L2 gene in omental and subcutaneous adipose tissue and risk of type 2 diabetes. PLoS ONE 4: e7231.
137. Prokunina-Olsson L, Welch C, Hansson O, Adhikari N, Scott LJ, Usher N, Tong M, Sprau A, Swift A, Bonnycastl LL, et al. 2009b. Tissue-specific alternative splicing o TCF7L2. Hum Mol Genet 18: 3795-3804.
138. Pukrop T, GradlD, Henningfeld KA, KnochelW, WedlichD, Kuhl M. 2001. Identification of two regulatory elements within the high mobility group box transcription facto XTCF-4. J Biol Chem 276: 8968-8978.
139. Read JT, Rahmani M, Boroomand S, Allahverdian S, McManu BM, Rennie PS. 2007. Androgen receptor regulation of the versican gene through an androgen response element in the proximal promoter. J Biol Chem 282: 31954-31963.
140. Reya T, O'Riordan M, Okamura R, Devaney E, Willert K, Nusse R, Grosschedl R. 2000. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13: 15-24.
141. Rios-Doria J, Kuefer R, Ethier SP, Day ML. 2004. Cleavage of β-catenin by calpain in prostate and mammary tumor cells. Cancer Res 64: 7237-7240.
142. Rocheleau CE, Downs WD, Lin R, Wittmann C, Bei Y, Ch YH, Ali M, Priess JR, Mello CC. 1997. Wnt signaling and an APC-related gene specify endoderm in early C. elegans embryos. Cell 90: 707-716.
143. Roose J, Molenaar M, Peterson J, Hurenkamp J, Brantjes H, Moerer P, van de Wetering M, DestreeO, Clevers H. 1998. The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature 395: 608-612.
144. Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R, Logtenberg T, Clevers H. 1999. Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1. Science 285: 1923-1926.
145. Satow R, Shitashige M, Jigami T, Honda K, Ono M, Hirohash S, Yamada T. 2010. Traf2-and Nck-interacting kinase is essential for canonical Wnt signaling in Xenopus axis formation. J Biol Chem 285: 26289-26294.
146. Savic D, Ye H, Aneas I, Park SY, Bell GI, Nobrega MA. 2011. Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Res 21: 1417-1425.
147. Schweizer L, Rizzo CA, Spires TE, Platero JS, Wu Q, Lin TA, Gottardis MM, Attar RM. 2008. The androgen receptor can signal through Wnt/β-catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens. BMC Cell Biol 9: 4.
148. Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Herrell R, Zinser G, Valrance M, Aranda A, Moras D, et al. 2006. The molecular basis of vitamin D receptor and β-catenin crossregulation. Mol Cell 21: 799-809.
149. Shetty P, Lo MC, Robertson SM, Lin R. 2005. C. elegans TCF protein, POP-1, converts from repressor to activator as a result of Wnt-induced lowering of nuclear levels. Dev Biol 285: 584-592.
150. Shitashige M, Satow R, Jigami T, Aoki K, Honda K, Shibat T, Ono M, Hirohashi S, Yamada T. 2010. Traf2-and Nckinteracting kinase is essential for Wnt signaling and colorectal cancer growth. Cancer Res 70: 5024-5033.
151. Sierra J, Yoshida T, Joazeiro CA, Jones KA. 2006. The APC tumor suppressor counteracts β-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev 20: 586-600.
152. Sjoblom T, Jones S, Wood LD, ParsonsDW, Lin J, BarberTD, MandelkerD, Leary RJ, Ptak J, Silliman N, et al. 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
153. Sokol SY. 2011. Maintaining embryonic stem cell pluripotency with Wnt signaling. Development (Cambridge, England) 138: 4341-4350.
154. Song LN, Gelmann EP. 2005. Interaction of β-catenin and TIF2/GRIP1 in transcriptional activation by the androgen receptor. J Biol Chem 280: 37853-37867.
155. Song LN, Herrell R, Byers S, Shah S, Wilson EM, Gelman EP. 2003. β-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription. Mol Cell Biol 23: 1674-1687.
156. Song H, Goetze S, Bischof J, Spichiger-Haeusermann C, Kuster M, Brunner E, Basler K. 2010. Coop functions as a corepressor of Pangolin and antagonizes Wingless signaling. Genes Dev 24: 881-886.
157. Srivastava M, Simakov O, Chapman J, Fahey B, Gauthier ME, Mitros T, Richards GS, Conaco C, Dacre M, Hellste U, et al. 2010. The Amphimedon queenlandica genome and the evolution of animal complexity. Nature 466: 720-726.
158. Stadeli R, Basler K. 2005. Dissecting nuclear Wingless signalling: Recruitment of the transcriptional co-activator Pygopus by a chain of adaptor proteins. Mech Dev 122: 1171-1182.
159. Standley HJ, Destree O, Kofron M, Wylie C, Heasman J. 2006. Maternal XTcf1 and XTcf4 have distinct roles in regulating Wnt target genes. Dev Biol 289: 318-328.
160. Steger DJ, Lefterova MI, Ying L, Stonestrom AJ, Schupp M, ZhuoD, Vakoc AL, Kim JE, Chen J, Lazar MA, et al. 2008. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol 28: 2825-2839.
161. Suganuma T, Workman JL. 2011. Signals and combinatorial functions of histone modifications. Annu Rev Biochem 80: 473-499.
162. Tang W, Dodge M, Gundapaneni D, Michnoff C, Roth M, Lum L. 2008. A genome-wide RNAi screen for Wnt/bcatenin pathway components identifies unexpected roles for TCF transcription factors in cancer. ProcNatl Acad Sci 105: 9697-9702.
163. Teo JL, Kahn M. 2010. The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators. Adv Drug Deliv Rev 62: 1149-1155.
164. Thorpe CJ, Schlesinger A, Carter JC, Bowerman B. 1997. Wnt signaling polarizes an early C. elegans blastomere to distinguish endoderm from mesoderm. Cell 90: 695-705.
165. Travis A, Amsterdam A, Belanger C, Grosschedl R. 1991. LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor a enhancer function. Genes Dev 5: 880-894.
166. Truica CI, Byers S, Gelmann EP. 2000. β-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res 60: 4709-4713.
167. Tsai BP, Wang X, Huang L, Waterman ML. 2011. Quantitative profiling of in vivo-assembled RNA-protein complexes using a novel integrated proteomic approach. Mol Cell Proteomics 10: M110.007385.
168. Tsedensodnom O, Koga H, Rosenberg SA, Nambotin SB, Carroll JJ, Wands JR, Kim M. 2011. Identification of Tcell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells. Exp Cell Res 317: 920-931.
169. Vacik T, Lemke G. 2011. Dominant-negative isoforms of Tcf/Lef proteins in development and disease. Cell Cycle 10: 4199-4200.
170. Valenta T, Lukas J, Korinek V. 2003. HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells. Nucleic Acids Res 31: 2369-2380.
171. van Beest M, Dooijes D, van De Wetering M, Kjaerulff S, Bonvin A, Nielsen O, Clevers H. 2000. Sequence-specific high mobility group box factors recognize 10-12-base pair minor groove motifs. J Biol Chem 275: 27266-27273.
172. van de Wetering M, Clevers H. 1992. Sequence-specific interaction of theHMGbox proteins TCF-1 and SRYoccurs within the minor groove of aWatson-Crick double helix. EMBO J 11: 3039-3044.
173. van de Wetering M, Oosterwegel M, Dooijes D, Clevers H. 1991. Identification and cloning of TCF-1, a T lymphocyte specific transcription factor containing a sequencespecific HMG box. EMBO J 10: 123-132.
174. van de Wetering M, Castrop J, Korinek V, Clevers H. 1996. Extensive alternative splicing and dual promoter usage generate Tcf-protein isoforms with differential transcription control properties. Mol Cell Biol 16: 745-752.
175. van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, Loureiro J, Ypma A, Hursh D, Jones T, Bejsovec A, et al. 1997. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88: 789-799.
176. van de Wetering M, Sancho E, Verweij C, de LauW, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, et al. 2002. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250.
177. Verras M, Brown J, Li X, Nusse R, Sun Z. 2004. Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells. Cancer Res 64: 8860-8866.
178. Voeller HJ, Truica CI, Gelmann EP. 1998. β-catenin mutations in human prostate cancer. Cancer Res 58: 2520-2523.
179. Wang G, Wang J, Sadar MD. 2008. Crosstalk between the androgen receptor and β-catenin in castrate-resistant prostate cancer. Cancer Res 68: 9918-9927.
180. Waterman ML, Fischer WH, Jones KA. 1991. A thymusspecific member of the HMG protein family regulates the human T cell receptor C a enhancer. Genes Dev 5: 656-669.
181. Weise A, Bruser K, Elfert S, Wallmen B, Wittel Y, Wohrl S, Hecht A. 2010. Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/β-catenin targets. Nucleic Acids Res 38: 1964-1981.
182. Willert K, Jones KA. 2006. Wnt signaling: Is the party in the nucleus? Genes Dev 20: 1394-1404.
183. Wohrle S, Wallmen B, Hecht A. 2007. Differential control of Wnt target genes involves epigenetic mechanisms and selective promoter occupancy by T-cell factors. Mol Cel Biol 27: 8164-8177.
184. Wright KJ, Tjian R. 2009. Wnt signaling targets ETO coactivation domain of TAF4/TFIID in vivo. Proc Natl Acad Sci 106: 55-60.
185. Wright JB, Brown SJ, Cole MD. 2010. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol Cell Biol 30: 1411-1420.
186. Yang X, van Beest M, Clevers H, Jones T, Hursh DA, Morti MA. 2000. Decapentaplegic is a direct target of dTcf repression in the Drosophila visceral mesoderm. Development (Cambridge, England) 127: 3695-3702.
187. Yang F, Li X, Sharma M, Sasaki CY, Longo DL, Lim B, Sun Z. 2002. Linking β-catenin to androgen-signaling pathway. J Biol Chem 277: 11336-11344.
188. Yang XD, Huang S, Lo MC, Mizumoto K, Sawa H, Xu W, Robertson S, Lin R. 2011. Distinct and mutually inhibitory binding by two divergent β-catenins coordinates TCF levels and activity in C. elegans. Development (Cambridge, England) 138: 4255-4265.
189. Yi F, Pereira L, Hoffman JA, Shy BR, Yuen CM, Liu DR, Merrill BJ. 2011. Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal. Nat Cell Biol 13: 762-770.
190. Yochum GS. 2011. Multiple Wnt/ss-catenin responsive enhancers align with the MYC promoter through longrange chromatin loops. PLoS ONE 6: e18966.
191. Yochum GS, Sherrick CM, Macpartlin M, Goodman RH. 2010. A β-catenin/TCF-coordinated chromatin loop at MYC integrates 5′and 3′Wnt responsive enhancers. Proc Natl Acad Sci 107: 145-150.
192. Yokoyama NN, Pate KT, Waterman ML. 2009. A role for YY1 in repression of dominant negative LEF-1 expression. Nucleic Acids Res 38: 6375-6388.
193. Yu X, Wang Y, Jiang M, Bierie B, Roy-Burman P, Shen MM, Taketo MM, Wills M, Matusik RJ. 2009. Activation of bcatenin in mouse prostate causes HGPINand continuous prostate growth aftercastration. The Prostate 69: 249-262.
194. Zhao JH, Luo Y, Jiang YG, He DL, Wu CT. 2011. Knockdown of β-catenin through shRNA cause a reversal of EMTand metastatic phenotypes induced by HIF-1a. Cancer Invest 29: 377-382.